Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection

Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection

Background: HLA-DM gene, which is related to antigen processing and presentation and located in the non-classical class-II region of human leukocyte antigen (HLA) region, may play a crucial role in chronic hepatitis C virus (HCV) infection treatment outcomes. The study was conducted to evaluate the...

Full description

Bibliographic Details
Main Authors: Hongbo Chen, Yinan Yao, Yifan Wang, Hua Zhou, Tianxiang Xu, Jing Liu, Guocheng Wang, Yongfeng Zhang, Xiang Chen, Qingwei Liu, Peng Huang, Rongbin Yu
Format: Article
Language:English
Published: MDPI AG 2016-10-01
Series:International Journal of Environmental Research and Public Health
Subjects:
hepatitis C
genetic polymorphism
HLA-DM gene
treatment outcome
Online Access:http://www.mdpi.com/1660-4601/13/10/1030

Internet

http://www.mdpi.com/1660-4601/13/10/1030

Similar Items